Literature DB >> 21999706

Intracellular Ca²⁺ signalling and phenotype of vascular smooth muscle cells.

Vladimir V Matchkov1, Olga Kudryavtseva, Christian Aalkjaer.   

Abstract

Vascular smooth muscle cells (VSMCs) express considerable plasticity in their phenotype and even can change their phenotype in vivo depending on the functional demand. In addition to contractile phenotype, VSMCs can be proliferative, migrating and/or synthetic. Importantly, contractile and non-contractile phenotypes differ significantly in their intracellular Ca²⁺ signalling, which is a consequence of difference in expression of Ca²⁺ transport proteins. Contractile VSMCs express Ca²⁺ transporters, including voltage-gated L-type Ca²⁺ channels and SERCA2a pump, which maintain low resting cytosolic Ca²⁺ and allow dynamic changes of Ca²⁺ in the spatial and temporal domain, while non-contractile VSMCs have significantly reduced voltage dependence of Ca²⁺ entry. These changes associated with phenotypic switch are consequences of changes in gene expression programmes, where the expression of phenotype-specific proteins and other proteins is suppressed. Importantly, Ca²⁺ -sensitive transcription factors, including serum response factor, cAMP response element-binding protein and nuclear factor of activated T lymphocytes, which are important for this phenotype switch, can be activated by different types of Ca²⁺ signalling. Thus, different Ca²⁺ transport proteins not only control averaged intracellular Ca²⁺ but also through their differences in the character of the Ca²⁺ signal modulate the activity of transcription factors and thus initiate phenotype switch. The essential stimuli for phenotype switch are unknown, but intracellular Ca²⁺ is an important second messenger in the cell transcription programme. This article reviews the relationship between intracellular Ca²⁺ signalling and VSMC phenotype.
© 2011 The Authors. Basic & Clinical Pharmacology & Toxicology © 2011 Nordic Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21999706     DOI: 10.1111/j.1742-7843.2011.00818.x

Source DB:  PubMed          Journal:  Basic Clin Pharmacol Toxicol        ISSN: 1742-7835            Impact factor:   4.080


  28 in total

Review 1.  Signaling in muscle contraction.

Authors:  Ivana Y Kuo; Barbara E Ehrlich
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-02-02       Impact factor: 10.005

2.  CCN4 regulates vascular smooth muscle cell migration and proliferation.

Authors:  Hao Liu; Wenpeng Dong; Zhiqi Lin; Jingbo Lu; Heng Wan; Zhongxin Zhou; Zhengjun Liu
Journal:  Mol Cells       Date:  2013-06-25       Impact factor: 5.034

Review 3.  Mechanisms of Vascular Smooth Muscle Contraction and the Basis for Pharmacologic Treatment of Smooth Muscle Disorders.

Authors:  F V Brozovich; C J Nicholson; C V Degen; Yuan Z Gao; M Aggarwal; K G Morgan
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

4.  Essential Role of Smooth Muscle STIM1 in Hypertension and Cardiovascular Dysfunction.

Authors:  Modar Kassan; Karima Ait-Aissa; Eman Radwan; Vishal Mali; Samuel Haddox; Mohanad Gabani; Wei Zhang; Souad Belmadani; Kaikobad Irani; Mohamed Trebak; Khalid Matrougui
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-07-28       Impact factor: 8.311

5.  MEF2B-Nox1 signaling is critical for stretch-induced phenotypic modulation of vascular smooth muscle cells.

Authors:  Andrés I Rodríguez; Gábor Csányi; Daniel J Ranayhossaini; Douglas M Feck; Kory J Blose; Lillian Assatourian; David A Vorp; Patrick J Pagano
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-12-30       Impact factor: 8.311

6.  Species-specific differences in the role of L-type Ca²⁺ channels in the regulation of coronary arterial smooth muscle contraction.

Authors:  Hui Yang; Su-Juan Kuang; Fang Rao; Yu-Mei Xue; Xiao-Ying Liu; Zhi-Xin Shan; Xiao-Hong Li; Jie-Ning Zhu; Zhi-Ling Zhou; Xiao-juan Zhang; Qiu-Xiong Lin; Xi-Yong Yu; Chun-Yu Deng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-02       Impact factor: 3.000

7.  CaMKIIδ-dependent inhibition of cAMP-response element-binding protein activity in vascular smooth muscle.

Authors:  Yongfeng Liu; Li-Yan Sun; Diane V Singer; Roman Ginnan; Harold A Singer
Journal:  J Biol Chem       Date:  2013-10-08       Impact factor: 5.157

8.  In vivo experimental stroke and in vitro organ culture induce similar changes in vasoconstrictor receptors and intracellular calcium handling in rat cerebral arteries.

Authors:  Gro Klitgaard Povlsen; Roya Waldsee; Hilda Ahnstedt; Kim Anker Kristiansen; Flemming Fryd Johansen; Lars Edvinsson
Journal:  Exp Brain Res       Date:  2012-05-15       Impact factor: 1.972

9.  Ginsenoside Rh1 Inhibits Angiotensin II-Induced Vascular Smooth Muscle Cell Migration and Proliferation through Suppression of the ROS-Mediated ERK1/2/p90RSK/KLF4 Signaling Pathway.

Authors:  Diem Thi Ngoc Huynh; Yujin Jin; Dung Van Nguyen; Chang-Seon Myung; Kyung-Sun Heo
Journal:  Antioxidants (Basel)       Date:  2022-03-27

10.  BMP-2 overexpression augments vascular smooth muscle cell motility by upregulating myosin Va via Erk signaling.

Authors:  Ming Zhang; Min Yang; Li-ping Liu; Wayne Bond Lau; Hai Gao; Man-kun Xin; Li-Xiao Su; Jian Wang; Shu-Juan Cheng; Qian Fan; Jing-Hua Liu
Journal:  Oxid Med Cell Longev       Date:  2014-03-20       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.